Posts filed under 'New Acne Products'
Youth Juice is a health drink that seems to be creating some serious buzz recently. YouthJuice or YJ as it is referred to by its many fans is a blend of 10 ingredients that offer an incredible level of antioxidants.
In addition to its high antioxidant capabilities, Youth Juice has been shown to be anti-inflammatory as well. This is clearly of interest to those with acne. Much of what drives acne is inflammation and many of the current prescription therapies that exist target this inflammation as a way of improving the acne itself.
There have been many anecdotal stories of how Youth Juice has helped those with allergies, colitis, arthritis and other inflammatory conditions. Here at Everything Acne.com we are excited to see if this revolutionary beverage will benefit those with acne as well.
If you have tried Youth Juice and it has helped your acne, please feel free to comment below. We will be following up with any new information regarding YJ and its effects on acne.
Click here to learn more about Youth Juice.
October 24th, 2009
Atralin gel is the newest branded retinoid to hit the acne market. Retinoids are a key component to any acne regimen and help mainly by normalizing keratinization. In other words, it helps the skin to slough off in the normal way in an effort to prevent blocking of pores. Dermatologists agree that retinoids, including Atralin gel are a key component both treating active ance as well as preventing futher breakouts.
While the benefits of retinoids, which include Differin gel and cream, Retin-a Microgel, Tazorec gel and cream, and now Atralin gel are well known, one of the potential drawbacks of these topical medications is their tendency to create dryness and irritation.
Atralin differs from its retinoid predecessors by including ingredients that attempt to combat dryness and even try and moisturize the skin. These ingredients include slouble collagen and Sodium Hyaluronate, both of which are moisturizers and glycerine which is a humectant and can help retain water and softness to the skin.
So, if you’re looking for the power of a retinoid with a more gentle gel, ask your dermatologist about Atralin gel.
April 20th, 2008
Benzaclin is one of the most popular topical acne treatments and is a member of the combination therapy family. Currently, Benzaclin is administered in a jar that is freshly mixed at the pharmacy.
We recently were informed that Dermik will soon be releasing a new packaging for the product that will contain a new dispensing mechanism. Stay tuned for updates.
March 30th, 2006
Adult acne in a very common problem. In fact, studies show that over 50% of women suffer from acne well after their teenage years.
For those women that do not require prescription treatment, there is a new product from Numark Laboratories called Acnomel. Acnomel is targeted for women with adult acne who may experience dryness with over the counter medications containing benzoyl peroxide.
Acnomel contains 2% resorcinol and 8% sulfur that is less likely to cause drying. So, if you suffer from adult acne, there is something new that may help.
February 18th, 2006
Another new acne treatment product has been held up by the FDA for further study. Velac is a combination clindamycin/tretinoin combination that was to be used for acne treatment. This combination acne treatment would bring the power of a topical antibiotic and topical retinoid in one easy application.
Connetics, the company behind Velac remains focused on bringing this product to market.
February 15th, 2006
Joining the topical benzoyl peroxide cleansing market is Zapzyt. Zapzyt 10% Benzoyl Peroxide bar is a soap-free cleanser that is marketed to help clear active blemishes as well as to help prevent new outbreaks. In the bar form, Zapzyt is easy to use on the face, back, and chest.
Zapzyt is priced to meet anyone’s budget and this may help increase its use and popularity in the topical acne over the counter market.
Learn more at here.
February 12th, 2006
Galderma was hoping to launch Differin XP in 2005, but delays from the FDA may move things back until late 2006.
This new formulation of Differin is a new offering to the topical retinoids. The 0.3% strength Differin XP has been proven in studies to be more effective at both reducing total lesion counts as well as reductions in both inflammatory (pimples and pustules) and non-inflammatory (blackheads and whiteheads) lesions than Differin 0.1% gel.
We will see where this fits in among other topical retinoids and look forward to possible head to head studies with Retin-a and Tazorac.
February 11th, 2006
One of the newest crazes in the treatment of acne has been the Zeno Acne Clearing Device. The device is revolutionary and over the counter and works by applying controlled heat to newly forming blemishes.
What’s important to know however, is that the Zeno device is not a cure-all for every type of acne. The Zeno Acne Clearing Device is indicated for mild to moderate acne and will not help those with more severe cystic acne.
To learn more about these indications visit our Zeno FAQs or Is Zeno for You pages.
February 6th, 2006
A new topical antibiotic cream may be emerging in the US market soon. Nadifloxacin is a new quinolone topical antibiotic in development in Japan. Nadifloxacin will come in a 0.44% cream. The DNA gyrase inhibitor has not suffered from any resistence patterns like other topical antibiotics incluing clindamycin and erythromycin.
Time will tell how this new product may be used in the fight against p. acnes and acne in general.
February 5th, 2006
Dapsone is an antibiotic that has been used for many disorders other than acne in the past. Until now, dapsone has only been available in an oral form with potential side effects involving the blood and nervous system.
Recently, the FDA approved a topical version of dapsone that will go by the trade name Aczone Topical Gel 5%. This topical version has very little absorption making it much safer than oral doses.
The medication shows both antibacterial and anti-inflammatory effects without bacterial resistence and has shown to be moderately effective for both acne vulgaris and rosacea.
The one downside is that the FDA will require an inital blood test prior to starting the medication. This may deter physcians from prescribing the new medication. We shall see.
February 4th, 2006
Previous Posts
